ChemoCentryx Inc (OQ:CCXI)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CCXI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 10th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 31/20 Mar 27/20 Jain Rita Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -5,251  
Mar 31/20 Mar 27/20 Jain Rita Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,251  
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -860 $38.21
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -13,959 $37.40
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -9,181 $36.72
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -2,801 $35.32
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -3,199 $34.43
Mar 5/20 Mar 4/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -40,844  
Mar 5/20 Mar 4/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -40,844 $50.35
Mar 5/20 Mar 4/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 40,844 $14.31
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CCXI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 10th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 31/20 Mar 2/20 Kwan Pui San Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 16,510  
Mar 31/20 Mar 27/20 Jain Rita Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -5,251  
Mar 31/20 Mar 27/20 Jain Rita Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,251  
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -860 $38.21
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -13,959 $37.40
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -9,181 $36.72
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -2,801 $35.32
Mar 25/20 Mar 23/20 Parker Geoffrey M. Indirect Ownership Common Stock S - Open market or private sale -3,199 $34.43
Mar 5/20 Mar 3/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 71,500  
Mar 5/20 Mar 3/20 Schall Thomas J. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 103,700  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CCXI

Competitors

Competitors with Recent Insider Filings
Apellis Pharmaceuticals (OQ:APLS)
Aptinyx (OQ:APTX)
BioMarin Pharmaceutical (OQ:BMRN)